BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27574180)

  • 1. Sphingosine-1-phosphate modulators in inflammatory skin diseases - lining up for clinical translation.
    Thieme M; Zillikens D; Sadik CD
    Exp Dermatol; 2017 Mar; 26(3):206-210. PubMed ID: 27574180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine-1-phosphate signaling and the skin.
    Herzinger T; Kleuser B; Schäfer-Korting M; Korting HC
    Am J Clin Dermatol; 2007; 8(6):329-36. PubMed ID: 18039015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of sphingosine 1-phosphate on functions of T cell - review].
    Huang WR; Wang LS; DA WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):718-22. PubMed ID: 16129068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling.
    Chew WS; Wang W; Herr DR
    Pharmacol Res; 2016 Nov; 113(Pt A):521-532. PubMed ID: 27663260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.
    Tsai HC; Han MH
    Drugs; 2016 Jul; 76(11):1067-79. PubMed ID: 27318702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement.
    Bordet R; Camu W; De Seze J; Laplaud DA; Ouallet JC; Thouvenot E
    Rev Neurol (Paris); 2020; 176(1-2):100-112. PubMed ID: 31757428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-phosphate receptor modulators in stroke treatment.
    Zhang W; Li Y; Li F; Ling L
    J Neurochem; 2022 Sep; 162(5):390-403. PubMed ID: 35943290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension.
    Meissner A; Miro F; Jiménez-Altayó F; Jurado A; Vila E; Planas AM
    Cardiovasc Res; 2017 Feb; 113(2):123-133. PubMed ID: 28082452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
    Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A
    Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy Treatment.
    Leo A; Citraro R; Marra R; Palma E; Paola EDD; Constanti A; De Sarro G; Russo E
    CNS Neurol Disord Drug Targets; 2017; 16(3):311-325. PubMed ID: 27823573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives.
    Bravo GÁ; Cedeño RR; Casadevall MP; Ramió-Torrentà L
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Egress: a receptor-regulated step in lymphocyte trafficking.
    Rosen H; Sanna G; Alfonso C
    Immunol Rev; 2003 Oct; 195():160-77. PubMed ID: 12969317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches.
    Halin C; Scimone ML; Bonasio R; Gauguet JM; Mempel TR; Quackenbush E; Proia RL; Mandala S; von Andrian UH
    Blood; 2005 Aug; 106(4):1314-22. PubMed ID: 15870184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from S1P receptor targeting in multiple sclerosis.
    Colombo E; Farina C
    Pharmacol Ther; 2022 Feb; 230():107971. PubMed ID: 34450231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology.
    von Wenckstern H; Zimmermann K; Kleuser B
    Arch Immunol Ther Exp (Warsz); 2006; 54(4):239-51. PubMed ID: 16830220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection.
    Tiper IV; East JE; Subrahmanyam PB; Webb TJ
    Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27354294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling.
    Szepanowski F; Derksen A; Steiner I; Meyer Zu Hörste G; Daldrup T; Hartung HP; Kieseier BC
    J Neuroinflammation; 2016 Jun; 13(1):143. PubMed ID: 27283020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.
    Proia RL; Hla T
    J Clin Invest; 2015 Apr; 125(4):1379-87. PubMed ID: 25831442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ['Vegetable wasps and plant worms' and G-protein-coupled receptors].
    Takeya H
    J UOEH; 2004 Jun; 26(2):227-38. PubMed ID: 15244075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration.
    Danese S; Furfaro F; Vetrano S
    J Crohns Colitis; 2018 Aug; 12(suppl_2):S678-S686. PubMed ID: 28961752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.